Intervention
Mazdutide
ClinicalTrials.gov intervention label
Clinical trials
11 shownPre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)NCT07718126 · 2026-09-01
RECRUITINGASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight ManagementNCT07517042 · 2026-06-10
RECRUITINGMazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)NCT07083154 · 2025-09-27
RECRUITINGA Study of HRS-4729 Injection in Participants With Type 2 DiabetesNCT07843862 · 2026-10-01
NOT_YET_RECRUITINGMazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled TrialNCT07767552 · 2026-09-30
NOT_YET_RECRUITINGMazdutide for Weight Management and Gout in Adults With ObesityNCT07824895 · 2026-09-15
NOT_YET_RECRUITINGQUARTET-DKD: Quadruple Therapy for Type 2 Diabetic NephropathyNCT07775846 · 2026-09-01
NOT_YET_RECRUITINGEffect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or ObesityNCT07657676 · 2026-09-01
NOT_YET_RECRUITINGMazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)NCT07654062 · 2026-07-01
NOT_YET_RECRUITINGA Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorNCT07417306 · 2026-03-27
NOT_YET_RECRUITINGA Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or OverweightNCT06124807 · 2023-11-17
COMPLETEDCommon conditions
Type 2 Diabetes3Obesity2Coronary Heart Disease1Dementia, Mild1Diabetes Mellitus, Type 21Gout1Hepatic Steatosis1Hyperuricemia1Impaired Fasting Glucose1Impaired Glucose Tolerance (Prediabetes)1Living Liver Donors1Metabolic Dysfunction-Associated Steatohepatitis1Metabolic Syndrome1Mild Cognitive Impairment1Obesity (BMI>30)1Obesity & Overweight1Overweight and Obesity1Prediabetes1Type 2 Diabetic Kidney Disease1Weight Control1
Leading sponsors
China National Center for Cardiovascular Diseases1Eli Lilly and Company1Fujian Shengdi Pharmaceutical Co., Ltd.1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1Hongwei Jiang1Huijie Zhang1Shandong Provincial Hospital1Shanghai Zhongshan Hospital1The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1West China Hospital1Yanbing Li1
Trial status mix
NOT_YET_RECRUITING7
RECRUITING3
COMPLETED1
Phase mix
PHASE45
NA2
PHASE22
PHASE32
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.